Open competition
Open procedure: the contract was advertised and any supplier could submit a bid.
Key facts
- Buyer
- NHS England · Body governed by public law
- Suppliers
- Pfizer Ltd, Takeda UK Ltd, Novo Nordisk, LFB, Bio Products Laboratory Ltd, CSL Behring UK Ltd, Octapharma Limited, Sobi (Swedish Orphan Biovitrum Ltd) SME, Roche Products Ltd
- Value
- £31 across 31 lots
- Procedure
- Open procedure
- Sector
- Medical equipment & pharmaceuticals · Pharmaceutical products (CPV 33600000)
- Region
- Yorkshire and the Humber
- Official notice
- 018011-2024 on Find a Tender
- Timeline
-
- Contract date31 May 2024
- Published11 Jun 2024Published 11 days after the contract date
Description
Standard Half-life Recombinant Factor VIII
Lots in this award
| Lot | Supplier | Value |
|---|---|---|
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024: CM/PHS/22/5661/01 Standard Half-life Recombinant Factor VIII | Pfizer Ltd | £1 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024: CM/PHS/22/5661/07 rFIX - Standard Half Life | Pfizer Ltd | £1 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024: CM/PHS/22/5661/07 rFIX - Standard Half Life | Takeda UK Ltd | £1 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024: CM/PHS/22/5661/08 Recombinant Factor VII | Novo Nordisk | £1 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024: CM/PHS/22/5661/08 Recombinant Factor VII | LFB | £1 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024: CM/PHS/22/5661/09 Porcine Factor VIII - susoctocog alfa | Takeda UK Ltd | £1 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024: CM/PHS/22/5661/10 Factor VIII Inhibitor Bypassing Fraction | Takeda UK Ltd | £1 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024: CM/PHS/22/5661/11 Factor IX - High Purity Factor IX | Bio Products Laboratory Ltd | £1 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024: CM/PHS/22/5661/12 Factor X | Bio Products Laboratory Ltd | £1 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024: CM/PHS/22/5661/13 Factor XIII - Plasma Derived | CSL Behring UK Ltd | £1 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024: CM/PHS/22/5661/14 Factor XIII - Recombinant | Novo Nordisk | £1 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024: CM/PHS/22/5661/01 Standard Half-life Recombinant Factor VIII | Takeda UK Ltd | £1 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024: CM/PHS/22/5661/15 Von willebrands factor / Factor VIII | Octapharma Limited | £1 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024: CM/PHS/22/5661/15 Von willebrands factor / Factor VIII | CSL Behring UK Ltd | £1 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024: CM/PHS/22/5661/16 Von willebrands factor - Plasma Derived | LFB | £1 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024: CM/PHS/22/5661/17 Von willebrands factor - Recombinant | Takeda UK Ltd | £1 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024: CM/PHS/22/5661/18 Fibrinogen Concentrate | LFB | £1 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024: CM/PHS/22/5661/18 Fibrinogen Concentrate | Octapharma Limited | £1 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024: CM/PHS/22/5661/18 Fibrinogen Concentrate | CSL Behring UK Ltd | £1 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024: CM/PHS/22/5661/19 Prothrombin Complex dried | Takeda UK Ltd | £1 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024: CM/PHS/22/5661/19 Prothrombin Complex dried | Octapharma Limited | £1 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024: CM/PHS/22/5661/19 Prothrombin Complex dried | CSL Behring UK Ltd | £1 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024: CM/PHS/22/5661/01 Standard Half-life Recombinant Factor VIII | Octapharma Limited | £1 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024: CM/PHS/22/5661/20 Protein C Concentrate | Takeda UK Ltd | £1 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024: CM/PHS/22/5661/21 Fresh Frozen Plasma (all blood groups) | Octapharma Limited | £1 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024: CM/PHS/22/5661/02 Enhanced Half-life Recombinant Factor VIII | Novo Nordisk | £1 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024: CM/PHS/22/5661/02 Enhanced Half-life Recombinant Factor VIII | Sobi (Swedish Orphan Biovitrum Ltd) SME | £1 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024: CM/PHS/22/5661/03 Emicizumab | Roche Products Ltd | £1 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024: CM/PHS/22/5661/04 eftrenonacog alfa (rFIX EHL) | Sobi (Swedish Orphan Biovitrum Ltd) SME | £1 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024: CM/PHS/22/5661/05 albutrepenonacog alfa (rFIX EHL) | CSL Behring UK Ltd | £1 |
| NHS Framework - Blood Disorders including Haemophilia A and B - July 2024: CM/PHS/22/5661/06 nonacog beta pegol (rFIX EHL) | Novo Nordisk | £1 |
About the suppliers
Pfizer Ltd: every public contract they have won, plus their Companies House record (company 00526209).
Takeda UK Ltd: every public contract they have won, plus their Companies House record (company 03362860).
Octapharma Limited: every public contract they have won.
Novo Nordisk: every public contract they have won, plus their Companies House record (company 01118740).
Sobi (Swedish Orphan Biovitrum Ltd): every public contract they have won, plus their Companies House record (company 04369760).
Roche Products Ltd: every public contract they have won, plus their Companies House record (company 04369760).
CSL Behring UK Ltd: every public contract they have won, plus their Companies House record (company 01622483).
LFB: every public contract they have won, plus their Companies House record (company 01118740).
Bio Products Laboratory Ltd: every public contract they have won, plus their Companies House record (company 07343036).